Every year, millions of people become newly infected with HIV.

Kenya's health authorities have started offering lenacapavir, a long-acting HIV prevention drug administered by injection, free of charge to eligible patients, providing protection for six months.

Nigeria's Federal Government has confirmed that Lenacapavir, a breakthrough HIV prevention injection, will arrive in March. This twice-yearly PrEP drug has shown 100% effectiveness.

A new study has found that to escape a drug called lenacapavir, HIV has to damage one of its own components, the capsid. The finding reaffirmed the belief that the viral capsid is a good drug target and that the virus can’t afford to change it too much, opening the door to a new generation of drugs

No recklessness: State clarifies limits of new HIV prevention Lenacapavir  the-star.co.ke

Tanzania has officially registered Lenacapavir, a new drug, marking a significant advancement in the country's efforts for HIV prevention and treatment.